<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Hugel, Inc. — News on 6ix</title>
<link>https://6ix.com/company/hugel-inc</link>
<description>Latest news and press releases for Hugel, Inc. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Thu, 07 May 2026 05:39:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/hugel-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo68362cee78dffbe2df1463d5.webp</url>
<title>Hugel, Inc.</title>
<link>https://6ix.com/company/hugel-inc</link>
</image>
<item>
<title>Hugel reports record Q1 earnings, driving strong global growth in aesthetics</title>
<link>https://6ix.com/company/hugel-inc/news/hugel-reports-record-q1-earnings-driving-strong-global-growth-in-aesthetics</link>
<guid isPermaLink="true">https://6ix.com/company/hugel-inc/news/hugel-reports-record-q1-earnings-driving-strong-global-growth-in-aesthetics</guid>
<pubDate>Thu, 07 May 2026 05:39:00 GMT</pubDate>
<description>Hugel Inc., a leading global medical aesthetics company publicly traded in South Korea, has delivered record consolidated results for the first quarter. On Thursday, the company reported net sales of KRW116.6 billion, operating profit of KRW47.6 billion, and net profit of KRW40.6 billion for the January–March period this year, representing on-year increases of 29.9%, 22.3%, and 31.5%, respectively.</description>
</item>
<item>
<title>Hugel to enter ECM-based injectable market with aesthetic portfolio expansion</title>
<link>https://6ix.com/company/hugel-inc/news/hugel-to-enter-ecm-based-injectable-market-with-aesthetic-portfolio-expansion</link>
<guid isPermaLink="true">https://6ix.com/company/hugel-inc/news/hugel-to-enter-ecm-based-injectable-market-with-aesthetic-portfolio-expansion</guid>
<pubDate>Wed, 01 Apr 2026 02:30:00 GMT</pubDate>
<description>Hugel Inc., a leading global medical aesthetics company publicly traded in South Korea, has accelerated its growth strategy by adding an extracellular matrix (ECM)-based injectable treatment to its portfolio.</description>
</item>
<item>
<title>Hugel posts KRW105.9 billion in Q3 net sales on continued global growth</title>
<link>https://6ix.com/company/hugel-inc/news/hugel-posts-krw105-9-billion-054000475</link>
<guid isPermaLink="true">https://6ix.com/company/hugel-inc/news/hugel-posts-krw105-9-billion-054000475</guid>
<pubDate>Tue, 04 Nov 2025 05:40:00 GMT</pubDate>
<description>Hugel Inc., a leading global medical aesthetics company publicly traded in South Korea, announced its consolidated financial results for the third quarter of 2025 on Tuesday. The company reported KRW105.9 billion in net sales, KRW47.4 billion in operating profit, and KRW38 billion in net income, maintaining strong profitability with a 77% gross profit and 45% operating profit.</description>
</item>
<item>
<title>Hugel Inc. appoints Carrie Strom as Chief Executive Officer</title>
<link>https://6ix.com/company/hugel-inc/news/hugel-inc-appoints-carrie-strom-070000058</link>
<guid isPermaLink="true">https://6ix.com/company/hugel-inc/news/hugel-inc-appoints-carrie-strom-070000058</guid>
<pubDate>Mon, 13 Oct 2025 07:00:00 GMT</pubDate>
<description>Hugel Inc., a leading global medical aesthetics company publicly traded in South Korea, announced today that industry veteran Carrie Strom has been appointed President and Global Chief Executive Officer, and is expected to be appointed to a member of the Board of Directors following approval at a forthcoming shareholders' meeting. Ms. Strom will start the newly established global CEO role on October 13, 2025. The Hugel Inc. executive leadership team will report directly to Ms. Strom, including t</description>
</item>
<item>
<title>Hugel hosts global H.E.L.F. symposium, marking 15 years of botulinum toxin Letybo</title>
<link>https://6ix.com/company/hugel-inc/news/hugel-hosts-global-h-e-003000119</link>
<guid isPermaLink="true">https://6ix.com/company/hugel-inc/news/hugel-hosts-global-h-e-003000119</guid>
<pubDate>Mon, 15 Sep 2025 00:30:00 GMT</pubDate>
<description>Hugel Inc., a leading global medical aesthetics company, hosted its global medical symposium H.E.L.F. in Seoul 2025 at Seoul Dragon City on September 14 to commemorate the 15th anniversary of the launch of its botulinum toxin Letybo.</description>
</item>
<item>
<title>Hugel strengthens Brazil presence with Letybo launch and new partner Derma Dream</title>
<link>https://6ix.com/company/hugel-inc/news/hugel-strengthens-brazil-presence-letybo-003000939</link>
<guid isPermaLink="true">https://6ix.com/company/hugel-inc/news/hugel-strengthens-brazil-presence-letybo-003000939</guid>
<pubDate>Mon, 08 Sep 2025 00:30:00 GMT</pubDate>
<description>Hugel Inc., a leading global medical aesthetics company chaired by Suk Cha, is accelerating its growth in Brazil – one of Latin America's key markets – through a distribution agreement with Derma Dream for its botulinum toxin product Letybo.</description>
</item>
<item>
<title>Hugel launches botulinum toxin Letybo in Malaysia</title>
<link>https://6ix.com/company/hugel-inc/news/hugel-launches-botulinum-toxin-letybo-003000515</link>
<guid isPermaLink="true">https://6ix.com/company/hugel-inc/news/hugel-launches-botulinum-toxin-letybo-003000515</guid>
<pubDate>Mon, 11 Aug 2025 00:30:00 GMT</pubDate>
<description>Hugel Inc., a leading global medical aesthetics company chaired by Suk Cha, has officially launched its botulinum toxin product Letybo in Malaysia – an emerging market for medical aesthetics in Southeast Asia.</description>
</item>
<item>
<title>Hugel posts record first-half net sales exceeding KRW200 billion in H1 2025</title>
<link>https://6ix.com/company/hugel-inc/news/hugel-posts-record-first-half-060000015</link>
<guid isPermaLink="true">https://6ix.com/company/hugel-inc/news/hugel-posts-record-first-half-060000015</guid>
<pubDate>Wed, 06 Aug 2025 06:00:00 GMT</pubDate>
<description>Hugel Inc., a leading global medical aesthetics company, announced its consolidated financial results for the second quarter of 2025 on Wednesday. The company posted KRW110.3 billion in net sales, KRW56.7 billion in operating profit, and KRW38.2 billion in net income, representing on-year increases of 15.5%, 33.6%, and 3.3%, respectively. These results mark the highest quarterly figures in the company's history and contributed to a record first-half performance.</description>
</item>
<item>
<title>Hugel posts KRW89.8 billion in net sales, marking record Q1 earnings</title>
<link>https://6ix.com/company/hugel-inc/news/hugel-posts-krw89-8-billion-070000843</link>
<guid isPermaLink="true">https://6ix.com/company/hugel-inc/news/hugel-posts-krw89-8-billion-070000843</guid>
<pubDate>Thu, 08 May 2025 07:00:00 GMT</pubDate>
<description>Hugel Inc., a leading global medical aesthetics company chaired by Suk Cha, on May 8 posted KRW89.8 billion, KRW39.0 billion, and KRW30.9 billion for the first quarter net sales, operating profit, and net profit, respectively, based on a consolidated financial statement. With the highest-ever first-quarter earnings for the company, the figures represent increases of 20.9%, 62.6%, and 35.9%, respectively, compared with the same period of 2024.</description>
</item>
</channel>
</rss>